Esperion Therapeutics, Inc. announced the appointment of Sheldon Koenig as the company’s Chief Operating Officer pursuant to the terms of an employment agreement with Mr. Koenig (the “Koenig Agreement”), effective as of December 15, 2020. Mr. Koenig, 55, served as Executive Vice President and Chief Commercial Officer at Portola Pharmaceuticals, Inc. from January 2019 to August 2020. From January 2016 to July 2018, Mr. Koenig was senior vice president and head of the cardiovascular franchise for Sanofi where he led U.S. business operations and product launches internationally. Prior to that, Mr. Koenig served as vice president and global brand leader for the cardiovascular division of Merck & Co, Inc. where, for more than 25 years, he took on roles of increasing responsibility within the company’s cardiovascular and thrombosis franchises and led marketing for the launch of ezetimibe.